{"entity":{"id":"stcube","kind":"company","name":"STCube","aka":["STCube, Inc."],"tldr":"STCube is a South Korea-based biotechnology company running 2 late-stage cancer trials of Nelmastobart in non-small-cell lung cancer and colorectal cancer.","summary":"STCube, based in Seoul, South Korea, is a biotechnology company. STCube (STCube Pharmaceuticals) develops immunotherapy drugs targeting novel immune checkpoints, with a lead focus on inhibiting BTN1A1 in cancer. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials, testing Nelmastobart in non-small-cell lung cancer and colorectal cancer. The largest, NCT07306624 (Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer), plans to enrol 62 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://www.stcube.com/"},{"label":"ClinicalTrials.gov: trials led by STCube","url":"https://clinicaltrials.gov/search?lead=STCube%2C%20Inc."}],"tags":["ctgov-sponsor"],"related":[],"cancers":["nsclc","colorectal"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct07306624","nct06873763"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Seoul","country":"KR","companyType":"biotech","website":"https://www.stcube.com/","stage":"growth","investors":[],"funding":[]},"route":"/companies/stcube/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"trial":[{"id":"nct07306624","kind":"trial","name":"Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer","route":"/trials/nct07306624/"},{"id":"nct06873763","kind":"trial","name":"Nelmastobart in Combination With Trifluridine/ Tipiracil and Bevacizumab in Metastatic/ Recurrent Colorectal Cancer","route":"/trials/nct06873763/"}]}}